SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Pharmos (PARS)
An SI Board Since October 1998
Posts SubjectMarks Bans Symbol
1386 42 0 PARS
Emcee:  Dr. John M. de Castro Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
611 Dear Dr. John: PARS drew down $300,000 from the credit line to INSURE that ThDavid Israel-Rosen-3/5/1999
610 Last year Pharmos had to raise 5 million this year they stated that with the yosi s-3/5/1999
609 An analysis of PARS cash flows during Q4 suggests that PARS drew down about $30Dr. John M. de Castro-3/5/1999
608 There will be a conference call. Do not know when, yosi s-3/4/1999
607 Omer- Your comments on product samples was one that I tried to raise quite someTony van Werkhooven-3/4/1999
606 Yosi- do you know if there will be a scheduled conference call? Thanks Tony Tony van Werkhooven-3/4/1999
605 John, Your interpretation about "gearing up for PIII" is quite correOmer Shvili-3/4/1999
604 CONGRATS TO PHARMOS ON GREAT Q 4 RELEASE. Pharmos always stated that 99 will byosi s-3/4/1999
603 John- Your interpretation is what I would also have come up with. Another intTony van Werkhooven-3/4/1999
602 This is a rather remarkable statement in the Q4 release. "The Company is Dr. John M. de Castro-3/4/1999
601 March 04, 1999 17:28 Pharmos Corporation's Fourth Quarter Net Improves 39%Tony van Werkhooven-3/4/1999
600 PARS releases 4th Qtr Earnings. Available at: newsalert.com 4th. Qtr 1998 -$0Rick Strange-3/4/1999
599 Omer- Once we get the year end financials, it would be interesting to build a mTony van Werkhooven-3/4/1999
598 "Pharmos believes that its current cash resources should be sufficient to yosi s-3/4/1999
597 I doubt that Centenial is responsible for the shorts. Here's an interestingDr. John M. de Castro-3/4/1999
596 Check out PARS new SEC Filing from Today, This might explain the Short sellingDavid Israel-Rosen-3/4/1999
595 PARS registers 1 million shares to cover Centennial Parkway LLC line of credit Dr. John M. de Castro-3/4/1999
594 <One way to follow growth, is to monitor month to month growth of new prescLLCF-3/4/1999
593 In regards to revenue growth. One way to follow growth, is to monitor month tyosi s-3/4/1999
592 <Omer: Thanks for the superb summary; it was most enlightening.> AbsoluLLCF-3/4/1999
591 Omer: Thanks for the superb summary; it was most enlightening. From the perspecarnie h-3/4/1999
590 Arnie, I don't know why you are so disappointed with BOL's sales. TheiOmer Shvili-3/4/1999
589 Arnie: Unlike the rest of us Omer visits on a regular basis with mgt which upDavid Israel-Rosen-3/3/1999
588 Omer: >I also agree that the ophthalmic line doesn't excite most peoplarnie h-3/2/1999
587 johnny weissman---easier said than done! Ron-3/2/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):